Eversept Partners, LP Concert Pharmaceuticals, Inc. Transaction History

Eversept Partners, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.86 - $13.07 $504,608 - $1.36 Million	-103,829 Closed	0 $0
Q4 2020 Nov 08, 2023	BUY	$9.48 - $12.84 $984,298 - $1.33 Million	103,829 New	103,829 $1.31 Million
Q3 2020 Nov 08, 2023	SELL	$8.67 - $10.82 $1.12 Million - $1.4 Million	-129,154 Reduced 55.43%	103,829 $1.02 Million
Q3 2020 Nov 13, 2020	SELL	$8.67 - $10.82 $1.12 Million - $1.4 Million	-129,154 Reduced 55.43%	103,829 $1.02 Million
Q2 2020 Nov 08, 2023	BUY	$7.8 - $11.52 $1.45 Million - $2.14 Million	185,829 Added 394.09%	232,983 $2.32 Million
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $1.82 Million - $2.68 Million	232,983 New	232,983 $2.32 Million
Q2 2019 Aug 13, 2019	SELL	$9.44 - $13.12 $445,133 - $618,660	-47,154 Closed	0 $0
Q1 2019 Nov 08, 2023	BUY	$12.07 - $17.54 $569,148 - $827,081	47,154 New	47,154 $569,000
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $569,148 - $827,081	47,154 New	47,154 $569,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.